Go to the list of all blogs
Allana's Avatar
published in Blogs
Nov 07, 2026
TickeronGET DAILY SIGNALS
Vanguard Mega Cap Value ETF (MGV): Assessing the Path to $200

Vanguard Mega Cap Value ETF (MGV): Assessing the Path to $200

Key Takeaways

  • MGV is an ETF tracking the CRSP US Mega Cap Value Index with over 120 large U.S. value holdings, a 0.05% expense ratio, and roughly $13.8 billion in AUM.
  • The $200 target stems from weight-adjusted analyst price targets on the fund’s top holdings rather than any direct consensus on the ETF itself, implying about 20% upside from recent levels.
  • At a recent price near $169, reaching $200 would require an advance of approximately 18%.
  • A broader 12-month holdings-based view points to an average near $177, with a range from about $149 to $205.
  • Supportive elements include a tilt toward financials, energy, and healthcare, a dividend yield near 1.9%, low costs, and value-sector rotation.
  • Key risks involve financial-sector concentration, interest-rate sensitivity, and a roughly 5% position in Micron Technology.

How the $200 Target Emerged

Because MGV is an ETF, no sell-side analyst issues a standalone price target for the fund. The $200 level instead reflects public analysis that looks through to the holdings. In October 2026, one calculation placed the weight-adjusted average analyst target on the top ten holdings—representing about 29% of the fund—roughly 20.3% above the then-prevailing price, pointing toward the high $190s to low $200s. Similar implied-target work has appeared over the past two years. Rounding the holdings-based upside to the clean $200 figure creates a psychologically appealing benchmark rather than a formal forecast.

A wider 12-month holdings-based perspective compiled elsewhere implied an average around $177, spanning roughly $149 to $205. That range captures the dispersion of views across the fund’s approximately 120 constituents.

Current Market Position and the Road Ahead

MGV closed near $169.00 in late October 2026, close to the top of its 52-week range of $135.26 to $169.84. An 18% advance to $200 would represent a meaningful move for a diversified, low-beta fund that typically trails the broader market’s volatility. The most likely route would involve continued strength in the heaviest sectors. Financials, including JPMorgan Chase (JPM) and Bank of America (BAC), account for about a quarter of assets and tend to benefit from economic resilience and stable long-term yields. Energy and healthcare holdings such as Exxon Mobil (XOM) and Johnson & Johnson (JNJ) provide additional earnings and dividend support.

Factors That Could Drive Gains

  • Value rotation. MGV has outperformed growth-oriented benchmarks over the past year, with several 2026 analyses highlighting attractive valuation and momentum characteristics.
  • Earnings trajectory. Weighted estimates for the top holdings suggest roughly 8% earnings growth in the next fiscal year, offering a steadier foundation than price targets alone.
  • Income and efficiency. A dividend yield near 1.9% combined with the low 0.05% expense ratio supports long-term total returns.
  • Defensive tilt. A beta near 0.66 has historically limited downside participation relative to the broader market.

Risks That Could Limit Upside

  • Interest-rate exposure. With financials dominating, more aggressive Federal Reserve rate cuts than expected could compress bank margins and pressure performance.
  • Single-name concentration. Micron Technology (MU) represents about 5% of the fund and carries a wide target range, adding volatility.
  • Valuation considerations. The portfolio trades at a premium forward P/E relative to some broad benchmarks, leaving limited room for multiple expansion.
  • Sector rotation risk. A renewed technology-led rally could leave value areas lagging.

Technical Levels Worth Watching

The 52-week high near $169.84 serves as the first notable resistance, with the round $170 level just above. A sustained break above that zone would be required before any sustained move toward $200. On the downside, support appears near the $165 consolidation area and then lower around $154, a prior high that capped prices earlier in 2026. The 52-week low near $135 marks the broader trend floor. The $200 level itself remains a psychological round-number target with no established trading history, implying neither proven resistance nor proven demand.

Time Horizon and Items to Monitor

The holdings-based targets supporting the $200 discussion generally reflect a roughly 12-month horizon, though individual views vary. I’m watching MGV’s largest holdings’ earnings reports—particularly those of Micron, JPMorgan, and Exxon Mobil—along with Federal Reserve decisions and the fund’s monthly sector-weight and flow updates. A sustained shift in financials or a rotation back into growth could change the picture quickly. I also checked this using Tickeron’s AI Screener to compare sector exposures across similar value-oriented funds.

Exploring AI Daily Buy/Sell Signals

In my own process I occasionally reference Tickeron’s AI Daily Buy/Sell Signals to monitor momentum shifts across ETFs like MGV. The tool applies artificial intelligence to scan thousands of securities and generate Buy, Sell, or Hold signals based on technical behavior and market conditions. For a diversified fund such as this one, it can surface emerging trends more efficiently than manual review alone and serve as a useful complement to holdings analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MGV

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


MGV in -3.50% downward trend, sliding for three consecutive days on November 06, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MGV declined for three days, in 198 of 278 cases, the price declined further within the following month. The odds of a continued downward trend are 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for MGV moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 50 similar instances where the indicator moved out of overbought territory. In 32 of the 50 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 69 cases where MGV's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 70%.

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MGV as a result. In 55 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for MGV turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 35 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.

MGV broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

MGV moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for MGV crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +1.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where MGV advanced for three days, in 284 of 342 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 279 of 354 cases where MGV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

Notable companies

The most notable companies in this group are Walmart (NASDAQ:WMT), JPMorgan Chase & Co (NYSE:JPM), Micron Technology (NASDAQ:MU), ExxonMobil Holdings Corporation (NYSE:XOM), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Costco Wholesale Corp (NASDAQ:COST), Chevron Corp (NYSE:CVX), Coca-Cola Company (NYSE:KO), Procter & Gamble Company (NYSE:PG).

Industry description

The investment seeks the performance of the CRSP U.S. Mega Cap Value Index. The fund employs an indexing investment approach designed to track the performance of the index. The index is a float-adjusted, market-capitalization-weighted index designed to measure equity market performance of mega-capitalization value stocks in the United States. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Market Cap

The average market capitalization across the Vanguard Morningstar Mega Cap Value ETF (MGV) ETF is 176.54B. The market cap for tickers in the group ranges from 61.95B to 995.84B. WMT holds the highest valuation in this group at 995.84B. The lowest valued company is BSX at 61.95B.

High and low price notable news

The average weekly price growth across all stocks in the Vanguard Morningstar Mega Cap Value ETF (MGV) ETF was -2%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was 8%. NEM experienced the highest price growth at 13%, while DELL experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Vanguard Morningstar Mega Cap Value ETF (MGV) ETF was -22%. For the same stocks of the ETF, the average monthly volume growth was 22% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 71
P/E Growth Rating: 48
Price Growth Rating: 36
SMR Rating: 45
Profit Risk Rating: 47
Seasonality Score: 15 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category LargeValue

Category
Large Value
Address
Vanguard Health CarePo Box 2600 V26Valley Forge
Phone
N/A
Web
www.vanguard.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
Analysts expect Q1 2026 revenue of $3.00 billion, up 8% from $2.77 billion in the year-ago quarter. Consensus earnings per share (EPS) estimate stands at $4.31, reflecting steady profitability from the cystic fibrosis (CF) portfolio.